NeueHealth Financials

NEUE Stock   5.07  0.12  2.42%   
Based on the key indicators obtained from NeueHealth's historical financial statements, NeueHealth may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, NeueHealth's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 22.8 M, whereas Short and Long Term Debt Total is forecasted to decline to about 191.9 M. Key indicators impacting NeueHealth's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio0.740.7827
Notably Down
Slightly volatile
The essential information of the day-to-day investment outlook for NeueHealth includes many different criteria found on its balance sheet. An individual investor should monitor NeueHealth's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in NeueHealth.

Net Income

(1.21 Billion)

  
Understanding current and past NeueHealth Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of NeueHealth's financial statements are interrelated, with each one affecting the others. For example, an increase in NeueHealth's assets may result in an increase in income on the income statement.
Please note, the presentation of NeueHealth's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NeueHealth's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of NeueHealth's management manipulating its earnings.

NeueHealth Stock Summary

NeueHealth competes with Radcom, Parker Hannifin, Western Copper, Grupo Televisa, and NioCorp Developments. NeueHealth is entity of United States. It is traded as Stock on NYSE exchange.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS10920V4041
CUSIP10920V107 10920V404
Older SymbolBHG
LocationMinnesota; U.S.A
Business Address9250 NW 36th
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.neuehealth.com
Phone612 238 1321

NeueHealth Key Financial Ratios

NeueHealth Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NeueHealth's current stock value. Our valuation model uses many indicators to compare NeueHealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NeueHealth competition to find correlations between indicators driving NeueHealth's intrinsic value. More Info.
NeueHealth is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . At present, NeueHealth's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value NeueHealth by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

NeueHealth Systematic Risk

NeueHealth's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NeueHealth volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on NeueHealth correlated with the market. If Beta is less than 0 NeueHealth generally moves in the opposite direction as compared to the market. If NeueHealth Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NeueHealth is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NeueHealth is generally in the same direction as the market. If Beta > 1 NeueHealth moves generally in the same direction as, but more than the movement of the benchmark.

NeueHealth Thematic Clasifications

NeueHealth is part of Insurance investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Insurance industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
InsuranceView
This theme covers USA Equities from Insurance industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in NeueHealth Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NeueHealth's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of NeueHealth growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.00325

At present, NeueHealth's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.

NeueHealth November 22, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of NeueHealth help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NeueHealth. We use our internally-developed statistical techniques to arrive at the intrinsic value of NeueHealth based on widely used predictive technical indicators. In general, we focus on analyzing NeueHealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NeueHealth's daily price indicators and compare them against related drivers.

Complementary Tools for NeueHealth Stock analysis

When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios